序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
1 新型组合物 CN201280032195.7 2012-06-30 CN103620021A 2014-03-05 比吉特·伊德; 雅各布·布伦克·斯文森
发明涉及用于乳酸菌的干燥组合物,并且具体地涉及包含109至1013cfu/g组合物的乳酸菌细胞的干燥组合物,其中所述组合物的特征在于其还包含下列含量的保护剂(以下所有量的保护剂均相对于所述组合物中1g乳酸菌细胞确定):6-9g海藻糖、0.1-1g菊粉和0.5-3g酪蛋白,并且其不包含藻酸盐。所述组合物具有改善的感兴趣细胞的储存稳定性。在含有藻酸盐和不含藻酸盐的组合物间进行了比较试验,并且已经发现就稳定性而言在含藻酸盐或不含藻酸盐的组合物之间基本上没有差异。此外,本发明涉及制备干燥乳酸菌组合物的方法。
2 高产维生素K2的乳酸乳球菌菌株 CN201180050088.2 2011-08-11 CN103179863A 2013-06-26 克里斯蒂·加里格斯; 马丁·巴斯蒂安·皮德森
发明涉及一种新的、维生素K2产量增加的野生型乳酸乳球菌乳脂亚种细菌菌株及其突变体和变体,本发明还涉及生产用于减轻和/或预防维生素K缺乏的维生素K2强化的发酵食品或饲料产品以及维生素K强化的可食用产品的方法。本发明还涉及用本发明的方法可获得的发酵食品或饲料产品以及可食用产品,还涉及野生型乳酸乳球菌乳脂亚种细菌菌株用于治疗和/或预防哺乳动物诸如人的维生素K缺乏。
3 新型组合物 CN201280032195.7 2012-06-30 CN103620021B 2016-06-08 比吉特·伊德
发明涉及用于乳酸菌的干燥组合物,并且具体地涉及包含109至1013cfu/g组合物的乳酸菌细胞的干燥组合物,其中所述组合物的特征在于其还包含下列含量的保护剂(以下所有量的保护剂均相对于所述组合物中1g乳酸菌细胞确定):6-9g海藻糖、0.1-1g菊粉和0.5-3g酪蛋白,并且其不包含藻酸盐。所述组合物具有改善的感兴趣细胞的储存稳定性。在含有藻酸盐和不含藻酸盐的组合物间进行了比较试验,并且已经发现就稳定性而言在含藻酸盐或不含藻酸盐的组合物之间基本上没有差异。此外,本发明涉及制备干燥乳酸菌组合物的方法。
4 高产维生素K2的乳酸乳球菌菌株 CN201180050090.X 2011-08-11 CN103189498A 2013-07-03 克里斯蒂·加里格斯; 马丁·巴斯蒂安·皮德森
发明涉及一种新的、维生素K2产量增加的野生型乳酸乳球菌乳脂亚种细菌菌株及其突变体和变体,本发明还涉及生产用于减轻和/或预防维生素K缺乏的维生素K2强化的发酵食品或饲料产品以及维生素K强化的可食用产品的方法。本发明还涉及用本发明的方法可获得的发酵食品或饲料产品以及可食用产品,还涉及野生型乳酸乳球菌乳脂亚种细菌菌株用于治疗和/或预防哺乳动物诸如人的维生素K缺乏。
5 Lactococcus lactis strain with high vitamin K2 production US13816889 2011-08-11 US08673616B2 2014-03-18 Christel Garrigues; Martin Bastian Pedersen
The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2 production and mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
6 Vitamin k2 high productivity Lactococcus lactis strain JP2013524415 2011-08-11 JP2013534142A 2013-09-02 ガリーグ クリステル; バスティアン ペデルセン マルティン
本発明は、高いビタミンK2生産性を有する新規野生型ラクトコッカス・ラクティス亜種クレモリス菌株、及びその突然然変異体とバリアント、並びにビタミンK2が豊富な発酵食品又は飼料を製造する方法、並びにビタミンK欠乏症の改善及び/又は予防のためのビタミンKが豊富な食用製品に関する。 本発明はまた、本明細書中の方法によって得られる発酵食品若しくは飼料、及び食用製品に関し、そして哺乳動物、例えばヒトのビタミンK欠乏症の処置及び/又は予防に使用するための野生型ラクトコッカス・ラクティス亜種クレモリス菌株に関する。
7 Vitamin k2 high productivity Lactococcus lactis strain JP2013525235 2011-08-11 JP2013537427A 2013-10-03 ガリーグ クリステル; バスティアン ペデルセン マルティン
本発明は、高いビタミンK2生産性を有する新規野生型ラクトコッカス・ラクティス亜種クレモリス菌株、及びその突然然変異体とバリアント、並びにビタミンK2が豊富な発酵食品又は飼料を製造する方法、並びにビタミンK欠乏症の改善及び/又は予防のためのビタミンKが豊富な食用製品に関する。 本発明はまた、本明細書中の方法によって得られる発酵食品若しくは飼料、及び食用製品に関し、そして哺乳動物、例えばヒトのビタミンK欠乏症の処置及び/又は予防に使用するための野生型ラクトコッカス・ラクティス亜種クレモリス菌株に関する。
8 NOVEL COMPOSITIONS US15092473 2016-04-06 US20160235105A1 2016-08-18 BIRGITTE YDE; Jakob Blenker SVENDSEN
The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition.
9 LACTOCOCCUS LACTIS STRAIN WITH HIGH VITAMIN K2 PRODUCTION US13816889 2011-08-11 US20130142896A1 2013-06-06 Christel Garrigues; Martin Bastian Pedersen
The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2 production and mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
10 ANTI-LISTERIAL MIXED CULTURE AND METHOD FOR PRODUCING CHEESE US13541416 2012-07-03 US20130011516A1 2013-01-10 Carmel GRIFFIN; Susan Mills; Paul Ross; Willem Cornelis Meijer; Lourdes Mariela Serrano Davalos
The present invention discloses a method for producing a fermented dairy product, preferably cheese, comprising inoculating milk with lactic acid bacteria capable of producing a Class IIa type bacteriocin; and lactic acid bacteria capable of producing a Class I type bacteriocin.
11 Anti-listerial mixed culture and method for producing cheese US13541416 2012-07-03 US09332770B2 2016-05-10 Carmel Griffin; Susan Mills; Paul Ross; Willem Cornelis Meijer; Lourdes Mariela Serrano Davalos
The present invention discloses a method for producing a fermented dairy product, preferably cheese, comprising inoculating milk with lactic acid bacteria capable of producing a Class IIa type bacteriocin; and lactic acid bacteria capable of producing a Class I type bacteriocin.
12 Compositions US14129851 2012-06-30 US09308271B2 2016-04-12 Birgitte Yde
The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition.
13 NOVEL COMPOSITIONS US14129851 2012-06-30 US20140255366A1 2014-09-11 Birgitte Yde
The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition): from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition.
14 Lactococcus lactis strain with high vitamin K2 production US13817110 2011-08-11 US08765118B2 2014-07-01 Christel Garrigues; Martin Bastian Pedersen
The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2 production and mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
15 LACTOCOCCUS LACTIS STRAIN WITH HIGH VITAMIN K2 PRODUCTION US13817110 2011-08-11 US20130142765A1 2013-06-06 Christel Garrigues; MArtin Bastian Pedersen
The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2 production and mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
16 Drying lactic acid bacteria and new compositions EP14153377.8 2012-06-30 EP2730646A1 2014-05-14 Yde, Birgitte

The invention relates to a dry composition comprising from 109 to 1013 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition):

(i): from 2 to 9 g of sucrose, from 1 to 3 g of maltodextrin and from 0.75 to 2 g of Na-ascorbate.

The composition provides an improved storage stability of the cell of interest, by way of the specific ratio between the amount of cells and protective agents.

17 DRYING LACTIC ACID BACTERIA AND COMPOSITIONS EP12730974.8 2012-06-30 EP2726597B1 2017-11-15 YDE, Birgitte; SVENDSEN, Jakob, Blenker
18 PROCESS FOR MANUFACTURING OF A FERMENTED MILK PRODUCT EP15198332.7 2015-12-08 EP3178329A1 2017-06-14 AUBERT, Cécile; PRICE, Claire Emile

The present invention relates to a process for the manufacture of a fermented milk product comprising subjecting a milk base to mesophilic fermentation with a starter comprising a mesophilic culture and a weakly post-acidifying thermophilic culture until a desired pH value in the range of 4.0 and 5.0 is reached.

19 NOVEL COMPOSITIONS EP12730974.8 2012-06-30 EP2726597A1 2014-05-07 YDE, Birgitte; SVENDSEN, Jakob, Blenker
The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 10 9 to 10 13 cfu/g of the composition of lactic acid bacteria cells, wherein the composition is characterized by that it also comprises following amounts of protective agents (all amounts of protective agents below are given relative to 1 g of lactic acid bacteria cells in the composition) : from 6 to 9 g of trehalose, from 0.1 to 1 g of inulin and from 0.5 to 3 g of hydrolyzed casein, and by that it does not comprise a salt of alginic acid. The composition has an improved storage stability of the cell of interest. Comparison experiments have been made between compositions with and without alginate and it has been found that there is substantially no difference between compositions with or without alginate with regard to stability. Further, the invention relates to a method for preparing a dry lactic acid bacteria composition.
20 LACTOCOCCUS LACTIS STRAIN WITH HIGH VITAMIN K2 PRODUCTION EP11741595.0 2011-08-11 EP2606118A1 2013-06-26 GARRIGUES, Christel; PEDERSEN, Martin Bastian
The present invention relates to a novel wild-type Lactococcus lactis subsp. cremoris bacteria strain with increased vitamin K2productionand mutants and variants thereof and methods for preparation of a fermented food or feed product enriched in vitamin K2 and a vitamin K enriched edible product for amelioration and/or prevention of vitamin K deficiency. The present invention also relates to the fermented food or feed product and the edible product obtainable by the methods herein and to the wild-type Lactococcus lactis subsp. cremoris bacteria strain for use in treatment and/or prevention of vitamin K deficiency in a mammal, such as a human.
QQ群二维码
意见反馈